메뉴 건너뛰기




Volumn 66, Issue 12, 2013, Pages 1495-1501

Fragment screening by native state mass spectrometry

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DISCOVERY; HIGH-THROUGHPUT METHOD; NATIVE STATE; PROTEIN-LIGAND INTERACTIONS; SCREENING APPLICATION; SCREENING METHODS;

EID: 84891900325     PISSN: 00049425     EISSN: 14450038     Source Type: Journal    
DOI: 10.1071/CH13190     Document Type: Review
Times cited : (14)

References (44)
  • 9
    • 79952428086 scopus 로고    scopus 로고
    • doi:10.1016/B978-0-2-381274-2.00009-1
    • C. A. Lepre, Methods Enzymol. 2011, 493, 219. doi:10.1016/B978-0-2- 381274-2.00009-1
    • (2011) Methods Enzymol. , vol.493 , pp. 219
    • Lepre, C.A.1
  • 11
    • 79952383501 scopus 로고    scopus 로고
    • doi:10.1016/B978-0-2-381274-2.00008-X
    • A. M. Giannetti, Methods Enzymol. 2011, 493, 169. doi:10.1016/B978-0-2- 381274-2.00008-X
    • (2011) Methods Enzymol. , vol.493 , pp. 169
    • Giannetti, A.M.1
  • 12
    • 77956183412 scopus 로고    scopus 로고
    • Interrogation of Noncovalent Complexes by ESI-MS: A Powerful Platform for High Throughput Drug Discovery
    • (Eds K. T. Wanner, G. Hofner) Ch. 10, (Wiley-VCH Verlag GmbH & Co.: Weinheim). doi:10.1002/9783527610907.CH10
    • S. A. Hofstadler, K. A. Sannes-Lowery, Interrogation of Noncovalent Complexes by ESI-MS: A Powerful Platform for High Throughput Drug Discovery, in Mass Spectrometry in Medicinal Chemistry: Applications in Drug Discovery (Eds K. T. Wanner, G. Hofner) 2007, Ch. 10, pp. 321-338 (Wiley-VCH Verlag GmbH & Co.: Weinheim). doi:10.1002/9783527610907.CH10
    • (2007) Mass Spectrometry in Medicinal Chemistry: Applications in Drug Discovery , pp. 321-338
    • Hofstadler, S.A.1    Sannes-Lowery, K.A.2
  • 14
    • 33748527161 scopus 로고    scopus 로고
    • doi:10.2144/000112217
    • R. D. Smith, Biotechniques 2006, 41, 147. doi:10.2144/000112217
    • (2006) Biotechniques , vol.41 , pp. 147
    • Smith, R.D.1
  • 15
    • 0034716184 scopus 로고    scopus 로고
    • doi:10.1016/S1387-3806(00)00298-0
    • J. A. Loo, Int. J. Mass Spectrom. 2000, 200, 175. doi:10.1016/S1387- 3806(00)00298-0
    • (2000) Int. J. Mass Spectrom. , vol.200 , pp. 175
    • Loo, J.A.1
  • 21
    • 52049123291 scopus 로고    scopus 로고
    • doi:10.1016/J.DRUDIS. 2008.07.005
    • E. Freire, Drug Discov. Today 2008, 13, 869. doi:10.1016/J.DRUDIS. 2008.07.005
    • (2008) Drug Discov. Today , vol.13 , pp. 869
    • Freire, E.1
  • 27
    • 35348859706 scopus 로고    scopus 로고
    • doi:10.1002/CMDC. 200600298
    • A. Sinz, ChemMedChem 2007, 2, 425. doi:10.1002/CMDC. 200600298
    • (2007) ChemMedChem , vol.2 , pp. 425
    • Sinz, A.1
  • 34
  • 35
    • 35348861993 scopus 로고    scopus 로고
    • Tethering: Fragment-Based Drug Discovery by Mass Spectrometry
    • (Eds K. T. Wanner, G. Höfner) Ch. 9, (Wiley-VCH Verlag GmbH & Co.: Weinheim). doi:10.1002/9783527610907
    • M. T. Cancilla, D. A. Erlanson, Tethering: Fragment-Based Drug Discovery by Mass Spectrometry, in Mass Spectrometry in Medicinal Chemistry: Applications in Drug Discovery (Eds K. T. Wanner, G. Höfner) 2007, Ch. 9, pp. 305-320 (Wiley-VCH Verlag GmbH & Co.: Weinheim). doi:10.1002/9783527610907
    • (2007) Mass Spectrometry in Medicinal Chemistry: Applications in Drug Discovery , pp. 305-320
    • Cancilla, M.T.1    Erlanson, D.A.2
  • 37
    • 84865574659 scopus 로고    scopus 로고
    • doi:10.1002/CMDC.201200201
    • M. Sindelar, K. T. Wanner, ChemMedChem 2012, 7, 1678. doi:10.1002/CMDC.201200201
    • (2012) ChemMedChem , vol.7 , pp. 1678
    • Sindelar, M.1    Wanner, K.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.